Antigen presenting cells (APCs) are specialized immune cells that capture, process, and display foreign peptides on their surface in conjunction with major histocompatibility complex (MHC) molecules, thereby initiating adaptive immune responses. Understanding which cells serve as APCs, how they function, and why they are essential provides a foundation for grasping vaccine design, autoimmune disease mechanisms, and cancer immunotherapy Worth keeping that in mind..
Introduction to Antigen Presenting Cells
The immune system relies on a delicate balance between innate surveillance and adaptive specificity. While innate cells such as neutrophils and natural killer (NK) cells respond rapidly to pathogens, adaptive immunity requires a more sophisticated step: the presentation of antigenic peptides to T lymphocytes. This step is performed by antigen presenting cells, which bridge the innate and adaptive arms of immunity. APCs internalize antigens via phagocytosis, endocytosis, or macropinocytosis, degrade them into peptide fragments, load these fragments onto MHC class I or II molecules, and transport the complexes to the cell surface for T‑cell recognition.
Major Types of Antigen Presenting Cells
Although many cell types can express MHC molecules under certain conditions, professional APCs are distinguished by their high levels of MHC class II, co‑stimulatory molecules (CD80/CD86), and cytokines that promote T‑cell activation. The three classic professional APCs are:
- Dendritic cells (DCs)
- Macrophages
- B lymphocytes (B cells)
Each subset possesses unique features that tailor its role in different immunological contexts.
Dendritic Cells: The Premier APCs
Dendritic cells are considered the most potent APCs because they excel at capturing antigens in peripheral tissues, migrating to lymphoid organs, and activating naïve T cells.
- Origin: Derived from hematopoietic stem cells in the bone marrow; precursors include monocytes and lymphoid progenitors.
- Subsets: Conventional DCs (cDC1 and cDC2), plasmacytoid DCs (pDCs), and monocyte‑derived DCs (moDCs) under inflammatory conditions.
- Functional Highlights:
- Express high levels of MHC class II and co‑stimulatory molecules after maturation.
- Produce cytokines such as IL‑12 that drive Th1 differentiation.
- Capable of cross‑presentation: loading exogenous antigens onto MHC class I to activate CD8⁺ cytotoxic T cells.
Macrophages: Versatile Phagocytes with APC Capacity
Macrophages are tissue‑resident phagocytes that also function as APCs, particularly during the effector phase of immunity Most people skip this — try not to. Surprisingly effective..
- Location: Found in virtually all tissues (e.g., alveolar macrophages in lungs, Kupffer cells in liver).
- Antigen Uptake: Excel at phagocytosis of large particles, apoptotic cells, and microbes.
- APC Traits:
- Constitutively express MHC class II; expression increases upon activation by IFN‑γ or Toll‑like receptor (TLR) ligands.
- Secrete pro‑inflammatory cytokines (TNF‑α, IL‑1β, IL‑6) that shape the local immune milieu.
- Less efficient than DCs at activating naïve T cells but excel at stimulating memory or effector T cells already present in the tissue.
B Cells: Antigen‑Specific APCs
B lymphocytes are unique among APCs because their antigen capture is highly specific due to the B‑cell receptor (BCR).
- Mechanism: The BCR binds a specific epitope, internalizes the antigen, processes it, and presents peptides on MHC class II to helper T cells.
- Importance: This interaction provides the cognate help required for B‑cell proliferation, class‑switch recombination, and affinity maturation in germinal centers.
- Features:
- Express MHC class II constitutively; up‑regulate CD80/CD86 upon activation.
- Can also act as regulatory APCs by producing IL‑10 and inducing T‑regulatory cells under certain conditions.
Other Cells with Antigen‑Presenting Capabilities
Beyond the classic trio, several other cell types can present antigens under specific circumstances:
- Langerhans cells: Epidermal DCs that capture skin antigens and migrate to draining lymph nodes.
- Follicular dendritic cells (FDCs): Non‑hematopoietic stromal cells in lymphoid follicles that retain immune complexes on their surface for B‑cell selection, though they do not process antigens for MHC presentation.
- Endothelial cells: Can up‑regulate MHC class II during inflammation and present antigens to CD4⁺ T cells, contributing to peripheral tolerance or autoimmunity.
- Epithelial cells (e.g., intestinal epithelial cells): May express MHC class II and interact with intra‑epithelial lymphocytes, influencing mucosal immunity.
- Tumor cells: Some cancers aberrantly express MHC class I and co‑stimulatory molecules, enabling them to act as APCs, though often they evade immune detection by down‑regulating these molecules.
Mechanisms of Antigen Presentation: MHC Class I vs. MHC Class II Pathways
The immunological outcome depends on which MHC pathway processes the antigen.
MHC Class I Pathway (Endogenous)
- Source: Cytosolic proteins (viral proteins, tumor antigens, self‑proteins).
- Processing: Proteasome degradation → peptide transport into the ER via TAP → loading onto MHC class I → surface expression.
- Recognition: CD8⁺ cytotoxic T lymphocytes (CTLs) recognize peptide‑MHC I complexes, leading to target cell killing.
- Cross‑presentation: A specialized ability of certain DCs to externalize exogenous antigens onto MHC class I, crucial for priming CTLs against extracellular pathogens and tumors.
MHC Class II Pathway (Exogenous)
- Source: Extracellular proteins internalized by phagocytosis, endocytosis, or macropinocytosis.
- Processing: Acidification of phagosomes/endosomes → proteolysis by cathepsins → peptide loading onto MHC class II in the invariant chain (Ii)‑guided compartment (MIIC).
- Recognition: CD4⁺ helper T cells (Th) recognize peptide‑MHC II, providing help for B cells, macrophages, and other immune cells.
- Regulation: The invariant chain prevents premature peptide binding in the ER; HLA‑DM facilitates peptide exchange and removal of CLIP.
Role of APCs in Immune Responses
APCs orchestrate multiple phases of immunity:
- Initiation: DCs capture antigens at infection sites, mature, migrate to lymph nodes, and activate naïve T cells.
- Effector Phase: Macrophages and B cells present antigens to already‑activated T cells, amplifying cytokine production and antibody generation.
- Memory Formation: Persistent antigen presentation by DCs and B cells
